Deva Holding A.S. (IST:DEVA)

Market Cap	12.36B
Revenue (ttm)	14.70B
Net Income (ttm)	612.12M
Shares Out	200.02M
EPS (ttm)	3.06
PE Ratio	20.19
Forward PE	n/a
Dividend	0.29 (0.47%)
Ex-Dividend Date	Jun 25, 2024

Volume	373,200
Average Volume	504,669
Open	61.90
Previous Close	61.80
Day's Range	61.65 - 62.50
52-Week Range	51.00 - 81.30
Beta	-0.39
RSI	64.34
Earnings Date	Aug 15, 2025

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.